The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...
For the first time, a device for releasing local chemotherapy in the bladder has been approved in the U.S., for patients who do not respond to standard treatment.
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback